MENU
CRIS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Curis (CRIS) Ownership - Who owns Curis?

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
128 Spring Street
Phone
+1 617 503-6500
Employees
49
Web
https://www.curis.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
13.58M
P/E Ratio
N/A
Total Cash
9.05M
Projected Growth
N/A
Total Debt
1.97M
Revenue
11.65M
Risk (Beta)
5.44
Dividend Yield
N/A
Total Cash/Share
0.70
Total Debt/Equity
74.54
Revenue/Share
1.05 USD as % of share price

Fundamentals

CRIS
Capitalization
13.6M
P/E Ratio
N/A
Risk (Beta)
5.44
Dividend Yield
N/A
Total Cash
9.05M
Total Cash/Share
0.70
Total Debt
1.97M
Total Debt/Equity
74.54
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.05%
Revenue
11.6M
ROE
N/A
Book Value
-14.69M
P/B Ratio
3.10
Cash Flow
N/A
Earnings
-3.3
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
127K
Current Ratio
0.70
Current Revenue Per Employee
96242.42
Dividends Per Share - Security
N/A
EBITDA
-32.41M
Float
N/A
Float - Current
N/A
Gross Income Margin
99.53
Revenue To Assets
-104.28
Shares Held By Institutions
8.28M
Shares Outstanding - Current
12.9M
Total Liabilities
42.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-65.686
View a ticker or compare two or three
CRIS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a drug company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
128 Spring Street
Phone
+1 617 503-6500
Employees
49
Web
https://www.curis.com